Merck
MRK
#48
Rank
C$451.03 B
Marketcap
C$182.62
Share price
2.56%
Change (1 day)
68.75%
Change (1 year)

EPS for Merck (MRK)

EPS in 2026 (TTM): C$4.87

According to Merck's latest financial reports the company's current EPS (TTM) is C$5.05. In 2025 the company made an earnings per share (EPS) of C$10.34 an increase over its 2024 EPS that were of C$9.59.

EPS history for Merck from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C$4.87-52.89%
2025C$10.347.81%
2024C$9.594308.46%
2023C$0.22-97.32%
2022C$8.1310.92%
2021C$7.3384.68%
2020C$3.97-27.2%
2019C$5.4563.44%
2018C$3.34151.11%
2017C$1.33-54.58%
2016C$2.9330.21%
2015C$2.25-61.99%
2014C$5.91180.51%
2013C$2.11-31.82%
2012C$3.096.62%
2011C$2.90

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
C$12.40 145.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$9.96 97.34%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$1.86-63.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
C$5.12 1.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$40.06 693.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$20.55 307.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$3.63-28.05%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
C$5.05 0.07%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$5.52 9.25%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
C$1.94-61.49%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel